Market Overview:
The global colon targeting drug delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of drug delivery. Based on type, the global colon targeting drug delivery market is segmented into pressure controlled drug-delivery systems, novel colon targeted delivery system (CODESTM), osmotic controlled drug delivery (ORDS-CT), and others. The pressure controlled drug-delivery systems segment is expected to dominate the market during the forecast period owing to its advantages such as precise dosing and reduced side effects as compared to other types of colon targeteddrug delivery systems.Among these regions North America holds a dominant position followed by Europeand Asia Pacificregion s .
Product Definition:
A drug delivery system that delivers the drug to the colon. The importance of colon targeting drug delivery is that it can improve the absorption of drugs into the body, which can lead to better treatment outcomes.
Pressure Controlled Drug-Delivery Systems:
The global pressure controlled drug- delivery systems market was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is one of the major growth drivers for this market.
Novel Colon Targeted Delivery System (CODESTM):
New colon targeted delivery system (CODESTM) is a drug delivery technology that enables efficient and effective drug transport to the colon. It improves the bioavailability of drugs by improving their absorption, distribution, and excretion properties. CODESTM enhances drug efficacy by minimizing first pass metabolism thus increasing the amount of active ingredient reaching systemic circulation.
Application Insights:
The hospital segment dominated the global colon targeting drug delivery market in 2017 and is expected to maintain its lead over the forecast period. This can be attributed to factors such as increasing prevalence of chronic diseases, growing geriatric population, and rising healthcare expenditure. Moreover, a rise in number of hospitals & clinics has resulted in increased demand for targeted drug delivery systems. For instance, according to WHO¢â‚¬â„¢s Global Health Observatory (GHO), there were an estimated 1.9 billion adults aged 18 years or above across the globe as of 2016; out of which 940 million were women and 690 million men respectively.
Regional Analysis:
North America colon targeting drug delivery system market dominated the global industry in 2017. This can be attributed to the local presence of major players, high adoption rate of advanced therapeutics, and availability of well-developed healthcare infrastructure. The U.S., which is one of the most developed countries in terms of healthcare services and technologies, holds a significant share in North America region colon targeting drug delivery system market.
Asia Pacific is anticipated to register fastest growth over the forecast period owing to rising incidences associated with colorectal cancer coupled with increasing awareness about early diagnosis & treatment methods that are adopted by patients from developed regions such as Europe & North America for their diseases affecting internal organs such as liver or pancreas; thus driving demand for targeted drugs for these applications from emerging economies like China & India at a relatively lower price compared to developed regions thereby making Asia Pacific an attractive destination for pharmaceutical companies seeking profits through higher sales volumes at lower costs than other regions.
Growth Factors:
- Increasing incidence of colorectal cancer: The incidence of colorectal cancer is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits of people. This, in turn, is expected to boost the demand for colon targeting drug delivery systems in the coming years.
- Growing awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment for colorectal cancer. This is likely to fuel demand for colon targeting drug delivery systems in the near future.
- Technological advancements: The technological advancements in drug delivery systems are providing new opportunities for development of novel colon targeting drug delivery platforms. This is expected to create immense growth potential for this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Colon Targeting Drug Delivery Market Research Report
By Type
Pressure Controlled Drug-Delivery Systems, Novel Colon Targeted Delivery System (CODESTM), Osmotic Controlled Drug Delivery (ORDS-CT), Others
By Application
Hospital, Clinic, Biology Laboratory, Other
By Companies
Baxter International Inc., 3M Health Care, Bayer AG, Boston Scientific Corporation, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson and Johnson, Novartis AG, Sanofi SA, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Colon Targeting Drug Delivery Market Report Segments:
The global Colon Targeting Drug Delivery market is segmented on the basis of:
Types
Pressure Controlled Drug-Delivery Systems, Novel Colon Targeted Delivery System (CODESTM), Osmotic Controlled Drug Delivery (ORDS-CT), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Biology Laboratory, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter International Inc.
- 3M Health Care
- Bayer AG
- Boston Scientific Corporation
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Johnson and Johnson
- Novartis AG
- Sanofi SA
- Bausch Health
Highlights of The Colon Targeting Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pressure Controlled Drug-Delivery Systems
- Novel Colon Targeted Delivery System (CODESTM)
- Osmotic Controlled Drug Delivery (ORDS-CT)
- Others
- By Application:
- Hospital
- Clinic
- Biology Laboratory
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Colon Targeting Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Colon targeting drug delivery is a method of delivering drugs to the colon, where they can be more effectively absorbed and eliminated. This type of delivery is particularly useful for medications that are difficult or impossible to take by mouth, such as chemotherapy drugs.
Some of the major players in the colon targeting drug delivery market are Baxter International Inc., 3M Health Care, Bayer AG, Boston Scientific Corporation, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson and Johnson, Novartis AG, Sanofi SA, Bausch Health.
The colon targeting drug delivery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Colon Targeting Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Colon Targeting Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Colon Targeting Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Colon Targeting Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Colon Targeting Drug Delivery Market Size & Forecast, 2018-2028
4.5.1 Colon Targeting Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Colon Targeting Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Colon Targeting Drug Delivery Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Colon Targeting Drug Delivery Market Size Forecast by Type
5.2.1 Pressure Controlled Drug-Delivery Systems
5.2.2 Novel Colon Targeted Delivery System (CODESTM)
5.2.3 Osmotic Controlled Drug Delivery (ORDS-CT)
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Colon Targeting Drug Delivery Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Colon Targeting Drug Delivery Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Biology Laboratory
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Colon Targeting Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Colon Targeting Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Colon Targeting Drug Delivery Analysis and Forecast
9.1 Introduction
9.2 North America Colon Targeting Drug Delivery Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Colon Targeting Drug Delivery Market Size Forecast by Type
9.6.1 Pressure Controlled Drug-Delivery Systems
9.6.2 Novel Colon Targeted Delivery System (CODESTM)
9.6.3 Osmotic Controlled Drug Delivery (ORDS-CT)
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Colon Targeting Drug Delivery Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Biology Laboratory
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Colon Targeting Drug Delivery Analysis and Forecast
10.1 Introduction
10.2 Europe Colon Targeting Drug Delivery Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Colon Targeting Drug Delivery Market Size Forecast by Type
10.6.1 Pressure Controlled Drug-Delivery Systems
10.6.2 Novel Colon Targeted Delivery System (CODESTM)
10.6.3 Osmotic Controlled Drug Delivery (ORDS-CT)
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Colon Targeting Drug Delivery Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Biology Laboratory
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Colon Targeting Drug Delivery Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Colon Targeting Drug Delivery Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Colon Targeting Drug Delivery Market Size Forecast by Type
11.6.1 Pressure Controlled Drug-Delivery Systems
11.6.2 Novel Colon Targeted Delivery System (CODESTM)
11.6.3 Osmotic Controlled Drug Delivery (ORDS-CT)
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Colon Targeting Drug Delivery Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Biology Laboratory
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Colon Targeting Drug Delivery Analysis and Forecast
12.1 Introduction
12.2 Latin America Colon Targeting Drug Delivery Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Colon Targeting Drug Delivery Market Size Forecast by Type
12.6.1 Pressure Controlled Drug-Delivery Systems
12.6.2 Novel Colon Targeted Delivery System (CODESTM)
12.6.3 Osmotic Controlled Drug Delivery (ORDS-CT)
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Colon Targeting Drug Delivery Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Biology Laboratory
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Colon Targeting Drug Delivery Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Colon Targeting Drug Delivery Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Colon Targeting Drug Delivery Market Size Forecast by Type
13.6.1 Pressure Controlled Drug-Delivery Systems
13.6.2 Novel Colon Targeted Delivery System (CODESTM)
13.6.3 Osmotic Controlled Drug Delivery (ORDS-CT)
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Colon Targeting Drug Delivery Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Biology Laboratory
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Colon Targeting Drug Delivery Market: Competitive Dashboard
14.2 Global Colon Targeting Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Baxter International Inc.
14.3.2 3M Health Care
14.3.3 Bayer AG
14.3.4 Boston Scientific Corporation
14.3.5 F. Hoffmann-La Roche AG
14.3.6 GlaxoSmithKline PLC
14.3.7 Johnson and Johnson
14.3.8 Novartis AG
14.3.9 Sanofi SA
14.3.10 Bausch Health
